HCW Biologics (HCWB) Receivables (2020 - 2026)
HCW Biologics (HCWB) reported Receivables of $18,451 for Q2 2026, down 14.6% from $21,611 a year earlier and down 75.3% from the prior quarter.
Powered by 
Analysis
HCW Biologics (HCWB) Receivables (2020 - 2026) Analysis & Trends
At the end of FY2025, HCW Biologics posted Receivables of $32,175, down 94.5% from FY2024.
- Receivables has a five-year compound annual growth rate of -58.1% (FY2020 to FY2025).
- By year, Receivables came in at $582,201 in FY2024 (-62.1%), $1.54 million in FY2023 (+267.7%), $417,695 in FY2022 (+214.1%) and $133,000 in FY2021 (-94.7%).
- The Q2 2026 figure ranks as the lowest quarterly Receivables in data going back to Q4 2020.
- Year over year, Receivables has now declined in each of the last three quarters, with an average decline of 21.2% over the last eight quarters.
- The high point for year-over-year Receivables in five years was Q2 2022 (growth of 593.9%); the low point was Q2 2025 (a decline of 96.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $74,844 (Q1 2026), $32,175 (Q4 2025) and $2.03 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 25.23 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 18.99 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 13.51 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 12.74 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 16.16 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 10.35 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 5.01 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 14.19 Bn |
| 10 | HCW Biologics | 1.02 Mn | -4.00 Mn | -93,887.00 | 18,451.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18,451.00 |
| Mar 31, 2026 | 74,844.00 |
| Dec 31, 2025 | 32,175.00 |
| Sep 30, 2025 | 2.03 Mn |
| Jun 30, 2025 | 21,611.00 |
| Mar 31, 2025 | 87,493.00 |
| Dec 31, 2024 | 582,201.00 |
| Sep 30, 2024 | 651,840.00 |
| Jun 30, 2024 | 654,973.00 |
| Mar 31, 2024 | 903,884.00 |
| Dec 31, 2023 | 1.54 Mn |
| Sep 30, 2023 | 710,078.00 |
| Jun 30, 2023 | 707,211.00 |
| Mar 31, 2023 | 252,728.00 |
| Dec 31, 2022 | 417,695.00 |
| Sep 30, 2022 | 355,555.00 |
| Jun 30, 2022 | 346,934.00 |
| Mar 31, 2022 | 553,007.00 |
| Dec 31, 2021 | 133,000.00 |
| Sep 30, 2021 | 70,000.00 |
API Access
HCW Biologics Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=HCWB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "HCWB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=HCWB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();